Int Med - Digestv & Liver Dis

Medicine & Life Sciences

1. Acetaminophen 30%
2. Acids 16%
3. Acute Liver Failure 82%
4. Adenocarcinoma 19%
5. Alcohols 9%
6. alpha-Fetoproteins 10%
7. Anti-Inflammatory Agents 11%
8. Antibodies 12%
9. Antiviral Agents 16%
10. Aspirin 12%
11. Barrett Esophagus 83%
12. Bile Acids and Salts 23%
13. Biliary Liver Cirrhosis 24%
14. Biomarkers 15%
15. Biopsy 16%
16. Carcinogenesis 11%
17. Chemical and Drug Induced Liver Injury 15%
18. Cholesterol 48%
19. Chronic Hepatitis B 12%
20. Chronic Hepatitis C 28%
21. Colitis 11%
22. Colonoscopy 19%
23. Colorectal Neoplasms 19%
24. Confidence Intervals 11%
25. Copper 9%
26. Early Detection of Cancer 9%
27. End Stage Liver Disease 11%
28. Endoscopic Retrograde Cholangiopancreatography 12%
29. Endoscopy 14%
30. Eosinophilic Esophagitis 16%
31. Epithelial Cells 19%
32. Epithelium 12%
33. Esophageal Neoplasms 11%
34. Esophagitis 11%
35. Esophagogastric Junction 9%
36. Esophagus 17%
37. Fatty Acids 13%
38. Fatty Liver 12%
39. Fibrosis 63%
40. Gastroenterology 9%
41. Gastroesophageal Reflux 39%
42. Gene Expression 9%
43. Genes 17%
44. Genotype 12%
45. Hemorrhage 14%
46. Hepacivirus 41%
47. Hepatitis 15%
48. Hepatitis B 12%
49. Hepatitis B virus 14%
50. Hepatitis C 34%
51. Hepatocellular Carcinoma 100%
52. Hepatocytes 13%
53. Incidence 13%
54. Infections 12%
55. Inflammation 13%
56. Inflammatory Bowel Diseases 22%
57. Interferons 19%
58. LDL Cholesterol 11%
59. LDL Lipoproteins 13%
60. LDL Receptors 25%
61. Liver 83%
62. Liver Cirrhosis 10%
63. Liver Diseases 32%
64. Liver Neoplasms 13%
65. Liver Transplantation 52%
66. Lymphocytes 9%
67. Messenger RNA 12%
68. Meta-Analysis 10%
69. Metaplasia 14%
70. MicroRNAs 9%
71. Mortality 15%
72. Mutation 9%
73. Neoplasms 27%
74. Non-alcoholic Fatty Liver Disease 14%
75. Peptic Esophagitis 11%
76. Pharmaceutical Preparations 14%
77. Population 9%
78. Proprotein Convertase 9 10%
79. Proteins 17%
80. Proton Pump Inhibitors 19%
81. Ribavirin 19%
82. Safety 13%
83. Serum 21%
84. Sterol Regulatory Element Binding Protein 1 13%
85. Sterol Regulatory Element Binding Proteins 12%
86. Sterols 29%
87. Stomach 13%
88. Survival 27%
89. Systematic Reviews 10%
90. T-Lymphocytes 13%
91. Therapeutics 33%
92. Tissue Donors 9%
93. Transplant Recipients 9%
94. Transplantation 10%
95. Transplants 14%
96. Triglycerides 9%
97. Ulcerative Colitis 11%
98. Ursodeoxycholic Acid 9%
99. Virus Diseases 14%
100. Wounds and Injuries 19%